Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
MAIA Biotechnology, Inc. Common Stock
(NY:
MAIA
)
2.020
-0.020 (-0.98%)
Official Closing Price
Updated: 8:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
125,913
Open
2.020
Bid (Size)
1.960 (25)
Ask (Size)
2.180 (8)
Prev. Close
2.040
Today's Range
1.920 - 2.160
52wk Range
0.9901 - 5.990
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MAIA Biotechnology Announces Director Participation in Recent Private Placement Closings
December 19, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas
December 16, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
Performance
YTD
+69.75%
+69.75%
1 Month
-2.88%
-2.88%
3 Month
-28.87%
-28.87%
6 Month
-36.48%
-36.48%
1 Year
+81.98%
+81.98%
More News
Read More
MAIA Biotechnology Announces Private Placement of Approximately $950,000
December 09, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer
December 03, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private Placement
November 07, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
November 05, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces $2.44 Million Private Placement
October 28, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics
October 15, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology's Phase 2 Study Of THIO In Non-Small Cell Lung Cancer Shows Positive Interim Survival Benefits
September 11, 2024
Via
News Direct
MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer
September 10, 2024
From
MAIA Biotechnology
Via
Business Wire
MAIA Biotechnology to Present New Phase 2 Clinical Trial Data at the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Stock Earnings: MAIA Biotechnology Misses EPS for Q2 2024
August 16, 2024
Via
InvestorPlace
MAIA Biotechnology (MAIA) is one of the earliest pioneers of telomere targeting as a therapeutic strategy
July 23, 2024
Via
AB Newswire
Exposures
Product Safety
MAIA Biotechnology's Lung Cancer Drug Shows Promising Long-Term Benefits In Advanced Patients
July 23, 2024
Via
Benzinga
Why SAP Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
July 23, 2024
Via
Benzinga
MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent
July 23, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
FDA move illuminates key role of telomere targeting as a viable therapeutic strategy for cancer treatment
July 09, 2024
Via
AB Newswire
Exposures
COVID-19
Product Safety
Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 07, 2024
Via
Benzinga
MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy
June 07, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
New Clinical Data Reveals MAIA Biotechnology's THIO Achieves High Efficacy In Advanced Non-Small Cell Lung Cancer Treatment
June 07, 2024
Via
News Direct
Topics
Death
Exposures
Death
MAIA Biotechnology (MAIA): Pioneering New Frontiers in NSCLC Treatment with THIO
June 07, 2024
Via
AB Newswire
MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
June 06, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
Groundbreaking Study by MAIA Biotechnology (NYSE: MAIA) Indicates Promising New Treatment for Advanced Lung Cancer
June 06, 2024
Via
AB Newswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 04, 2024
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.